Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Fiona Powrie, Director of the Kennedy Institute will be speaking at The Times Cheltenham Science Festival, this Tuesday 2 June.

The Director of the Kennedy Institute, Professor Fiona Powrie will be speaking at The Times Cheltenham Science Festival, this June.

The event Our friendly bacteria will look at the microbiome - the population of more than 100 trillion microorganisms that live in our gut, mouth, skin and elsewhere in our bodies! - and how it links to our immune system. Immunologist Fiona Powrie will be joined by microbiologist Lindsay Hall and event chair Adam Hart; together they will explore our body's vital bacterial ecosystem and what happens when things go wrong: from allergies to cancer.

Are you around Cheltenham on Tuesday 2 June 14:30? Then join us for a lively discussion on how the immune system is keeping our teeth from falling out!

Get your ticket here

Similar stories

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.